Alginic acid Completed Phase 3 Trials for Gastro-esophageal Reflux Disease (GERD) / Dyspepsia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01869491Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study
NCT01872897Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients
NCT02623062Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study